Abbott Laboratories (ABT)vsInogen Inc (INGN)
ABT
Abbott Laboratories
$91.07
+0.56%
HEALTHCARE · Cap: $151.49B
INGN
Inogen Inc
$5.98
-1.81%
HEALTHCARE · Cap: $173.55M
Smart Verdict
WallStSmart Research — data-driven comparison
Abbott Laboratories generates 12741% more annual revenue ($45.13B vs $351.50M). ABT leads profitability with a 13.9% profit margin vs -7.1%. ABT appears more attractively valued with a PEG of 1.30. ABT earns a higher WallStSmart Score of 56/100 (C).
ABT
Buy56
out of 100
Grade: C
INGN
Hold49
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-28.5%
Fair Value
$70.89
Current Price
$91.07
$20.18 premium
Margin of Safety
+88.9%
Fair Value
$55.16
Current Price
$5.98
$49.18 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Reasonable price relative to book value
Earnings expanding 87.3% YoY
Conservative balance sheet, low leverage
Areas to Watch
Earnings declined 19.7%
3.4% revenue growth
Distress zone — elevated risk
Smaller company, higher risk/reward
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : ABT
The strongest argument for ABT centers on Market Cap. PEG of 1.30 suggests the stock is reasonably priced for its growth.
Bull Case : INGN
The strongest argument for INGN centers on Price/Book, EPS Growth, Debt/Equity.
Bear Case : ABT
The primary concerns for ABT are EPS Growth.
Bear Case : INGN
The primary concerns for INGN are Revenue Growth, Altman Z-Score, Market Cap.
Key Dynamics to Monitor
ABT profiles as a value stock while INGN is a turnaround play — different risk/reward profiles.
INGN carries more volatility with a beta of 1.59 — expect wider price swings.
ABT is growing revenue faster at 7.8% — sustainability is the question.
ABT generates stronger free cash flow (916M), providing more financial flexibility.
Bottom Line
ABT scores higher overall (56/100 vs 49/100). INGN offers better value entry with a 88.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Abbott Laboratories
HEALTHCARE · MEDICAL DEVICES · USA
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Visit Website →Inogen Inc
HEALTHCARE · MEDICAL DEVICES · USA
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians, and third-party payers in the United States and internationally. The company is headquartered in Goleta, California.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?